142 related articles for article (PubMed ID: 23453230)
1. [Update on hepatitis C therapy. New drugs, treatment response monitoring and emergence of resistance].
Chueca Porcuna N; Alvarez Estévez M; Parra Ruiz J; Hernández Quero J; García García F
Enferm Infecc Microbiol Clin; 2013 Feb; 31 Suppl 1():40-7. PubMed ID: 23453230
[TBL] [Abstract][Full Text] [Related]
2. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
[TBL] [Abstract][Full Text] [Related]
3. Future perspectives: towards interferon-free regimens for HCV.
Gane E
Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
[TBL] [Abstract][Full Text] [Related]
4. Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.
Shah N; Pierce T; Kowdley KV
Expert Opin Investig Drugs; 2013 Sep; 22(9):1107-21. PubMed ID: 23735127
[TBL] [Abstract][Full Text] [Related]
5. [Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].
Zuckerman E; Safadi R; Oren R; Shibolet O; Baruch Y; Bruck R; Lurei Y; Kaspa RT; Abu-Mouch S; Shouval D; Ben-Ari Z;
Harefuah; 2012 Dec; 151(12):709-14, 719. PubMed ID: 23330266
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus: standard-of-care treatment.
Pawlotsky JM
Adv Pharmacol; 2013; 67():169-215. PubMed ID: 23886001
[TBL] [Abstract][Full Text] [Related]
7. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
Butt AA; Kanwal F
Clin Infect Dis; 2012 Jan; 54(1):96-104. PubMed ID: 22156853
[TBL] [Abstract][Full Text] [Related]
8. New antiviral therapies in the management of HCV infection.
Farnik H; Zeuzem S
Antivir Ther; 2012; 17(5):771-83. PubMed ID: 22626842
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic approaches for hepatitis C.
Au JS; Pockros PJ
Clin Pharmacol Ther; 2014 Jan; 95(1):78-88. PubMed ID: 24126682
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of hepatitis C virus--2012: a real breakthrough].
Zuckerman E
Harefuah; 2012 Dec; 151(12):699-704, 719. PubMed ID: 23330264
[TBL] [Abstract][Full Text] [Related]
11. Drugs in development for chronic hepatitis C: a promising future.
Pockros PJ
Expert Opin Biol Ther; 2011 Dec; 11(12):1611-22. PubMed ID: 21995412
[TBL] [Abstract][Full Text] [Related]
12. [Direct antiviral treatment strategies in chronic hepatitis C].
Neumann-Haefelin C; Blum HE; Thimme R
Dtsch Med Wochenschr; 2012 Jun; 137(25-26):1360-5. PubMed ID: 22653493
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C treatment: an incipient therapeutic revolution.
deLemos AS; Chung RT
Trends Mol Med; 2014 Jun; 20(6):315-21. PubMed ID: 24636306
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of the new DAAs for the treatment of hepatitis C virus infection: virology and resistance.
Chevaliez S
Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S46-51. PubMed ID: 22248694
[TBL] [Abstract][Full Text] [Related]
15. Rapid progression of antiviral treatments of chronic hepatitis C virus infection.
Pol S; Corouge M; Mallet V; Sogni P
Minerva Gastroenterol Dietol; 2013 Jun; 59(2):161-72. PubMed ID: 23831907
[TBL] [Abstract][Full Text] [Related]
16. Telaprevir for the treatment of hepatitis C.
Forestier N; Zeuzem S
Expert Opin Pharmacother; 2012 Mar; 13(4):593-606. PubMed ID: 22332992
[TBL] [Abstract][Full Text] [Related]
17. [Chronic hepatitis C infection--eradication of the virus].
Ben Ari Z
Harefuah; 2014 Jul; 153(7):392-3, 433. PubMed ID: 25189028
[TBL] [Abstract][Full Text] [Related]
18. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
Welsch C; Jesudian A; Zeuzem S; Jacobson I
Gut; 2012 May; 61 Suppl 1():i36-46. PubMed ID: 22504918
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis C: perspectives.
Pol S; Corouge M
Med Mal Infect; 2014 Oct; 44(10):449-54. PubMed ID: 25174659
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]